Concurrent infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients positive for human immunodeficiency virus (HIV) is relatively common. The treatment of co-infected individuals is rather complex because the anti-viral therapy may be associated with drug-resistance, hepatotoxicity and lack of response. Herein, we present a summary of the available compounds and the recent recommendations concerning the therapeutic management of HIV/HBV and HIV/HCV co-infections.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/138955712800959062 | DOI Listing |
Publication Analysis
Top Keywords
hiv/hbv hiv/hcv
8
hepatitis virus
8
advances treatment
4
treatment hiv/hbv
4
hiv/hcv co-infection
4
co-infection concurrent
4
concurrent infection
4
infection hepatitis
4
virus hbv
4
hbv hepatitis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!